A woman in her late twenties has been off work for months. She’s exhausted, anxious in a way she’s never been before, and gaining weight she can’t explain.
When she points at the visible black mold growing in her apartment, her family physician tells her it isn’t the problem. A second physician agrees. By the end of the second appointment, she’s questioning whether she’s losing her grip on what’s real.
She was right about the mold. Both physicians were running the wrong test. In conventional medicine, mold-related illness is one of the most consistently missed diagnoses, and this isn’t the physician’s carelessness. The standard test is simply built to catch something else.
The mold that's still with you
Most patients who come in about mold have already ruled it out themselves. They live somewhere new, and they haven’t seen visible mold in years. With the current house smelling fresh, the logic feels airtight: if nothing is happening now, nothing from before could still be causing a problem.
Years after an exposure ends, sometimes a decade or more, it can still be affecting the body. A university dorm with black mold on the windowsills and behind the wall, a basement apartment in a rainy city, an office that flooded once and dried badly: any of those can be the source. The issue isn’t only whether mold is in the current environment. In many cases, the real question is whether mycotoxins are still in the tissue. The body doesn’t always release what it absorbed during the exposure.
This article is for you if:
Wrong test, wrong answer
When physicians test for mold, the conventional route runs through an IgE antibody panel, which looks for the immune response behind visible allergic reactions: sneezing, hives, watery eyes. For many patients, it comes back clean.
Once produced, mycotoxins, the chemical byproducts of mold, get processed through the liver and excreted through urine. On a urine mycotoxin panel, those byproducts show up directly. Patients who test negative on the antibody panel often come back significantly positive on the mycotoxin panel.
When two physicians look at the same clean IgE result, they arrive at the same conclusion. Neither of them is technically wrong. They’re checking the front door of the immune system, listening for the loud allergic reactions, while the toxins are being carried out the back door, into urine, every day. The right test was at a door no one had thought to watch.
There’s also a piece the conventional model doesn’t account for at all. About a quarter of the population carries a variant in their HLA-DR/DQ genes that impairs how efficiently the body clears mycotoxins. The variant doesn’t cause illness on its own. One person in a mold-affected house ends up significantly ill while the partner sharing the same space stays well. That’s the same reason one of our clinical team and her partner had to move homes. Although she was affected, her partner had no symptoms.
The HLA-DR/DQ genetic variant is one factor among several. Impaired detoxification pathways, prior chronic infections like Lyme, long COVID, low glutathione status, and earlier mold exposure as a child or teenager can each shift who gets sick from the same air. For a patient like this, affected when no one around her is, the test combined with the rest of her history often answers what the standard workup never could.
That gap is why a woman can be sick for ten years with a diagnosable condition and still be told nothing’s wrong.
They're checking the front door of the immune system, listening for the allergic reactions, while the toxins are being carried out the back door, into urine, every day.
When symptoms have an address
One observation turns a foggy clinical picture clear. Almost every chronically affected patient we see eventually says some version of the same thing: I feel better when I’m not home or at work.
Not slightly better. Better the way you notice when you’ve stopped doing something that was wearing you down. In a hotel room, the fatigue lifts. The brain fog clears on a weekend at a parent’s house. On vacation, the mood lightens, and you put it down to vacation, until you walk back through a familiar door and within a few days you’re back inside a fog you hadn’t realized you were in.
When a patient describes that pattern, the conversation shifts. Mold moves from a possible contributor to a probable one, and the testing follows.
Treatment starts in the moving truck
Treatment for mold illness doesn’t start in the pharmacy, but in the moving truck. Until the exposure ends, the body can’t get ahead of the load it’s being asked to clear. That part isn’t negotiable, and it comes first.
From there, the plan depends on how much, how long, and how depleted the patient already is. The young woman whose story opens this article was a simple case. Because her exposure had been short and she was otherwise healthy, we kept the treatment deliberately uncomplicated: a nasal spray for biofilm in the sinuses, an oral binder to pull mycotoxins out of the gut, liver and kidney support while the body cleared what it was carrying, and a diet full of antioxidants, polyphenols, and fiber to heal it. Vitamin D and glutathione went back in, because mold depletes both over months of exposure. Four weeks into the protocol, she described feeling like a different person.
Longer-exposure cases don’t always resolve that cleanly. When mold has been present for years, it often sits alongside chronic infections, Lyme disease, immune dysregulation, or chronic inflammatory response syndrome (CIRS). Treatment in those cases is layered and slower. What kills a protocol, even in the simpler cases, isn’t complexity. It’s continuing to live or work inside the environment that made her sick.
What kills a protocol, even in the simpler cases, isn't complexity. It's continuing to live or work inside the environment that made her sick.
Everything else checked out. Now what?
Usually, the clue isn’t a single symptom but a combination that has refused to resolve through everything else that’s been tried. Fatigue that doesn’t improve with sleep, brain fog that doesn’t lift with caffeine, anxiety or depression that arrived around the time a living situation changed and never fully left, weight that won’t move no matter the diet, or symptoms that follow you from room to room at home or at work and ease the moment you leave.
Before considering a mycotoxin panel, the standard investigations come first: routine bloodwork, thyroid function, and the workup a primary physician would run. Mold becomes the next question when those haven’t surfaced an answer. For patients whose symptoms have outlasted the standard workups, especially when a past or present exposure appears in their history, it’s a worthwhile test.
Plenty of our patients spent years being told the mold wasn’t the problem. When the right test showed it was, the relief wasn’t only physical. They’ve finally had their original instinct confirmed, and started to feel like themselves again.
If this sounds familiar, that recognition is worth bringing to a physician who works in this category and understands what mold exposure does to health and quality of life.